Rapid efficacy of a noradrenergic reuptake inhibitor in depression in advanced Parkinson's disease:: A double-blind, randomized, placebo-controlled study

被引：0
|
作者：
Devos, D.
Poirot, I.
Dujardin, K.
Duhem, S.
Lucas, B.
Waucquier, N.
Moreau, C.
Bocquillon, P.
Devos, P.
Ajebbar, K.
Thielemans, B.
Cottencin, O.
Thomas, P.
Destee, A.
Bordet, R.
Defebvre, L.
机构：
来源：
MOVEMENT DISORDERS | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
727
引用
收藏
页码：S223 / S224
页数：2
相关论文
共 50 条
  • [1] Atomoxetine for the Treatment of Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
    Weintraub, Daniel
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A67 - A67
  • [2] Atomoxetine for the treatment of depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Weintraub, D.
    Mavandadi, S.
    Horn, S.
    Hurtig, H.
    Siderowf, A.
    Duda, J.
    Stern, M.
    MOVEMENT DISORDERS, 2009, 24 : S286 - S286
  • [3] Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease
    Barone, P.
    Poewe, W.
    Tolosa, E.
    Rascol, O.
    Massey, D.
    Debieuvre, C.
    Albrecht, S.
    MOVEMENT DISORDERS, 2009, 24 : S347 - S347
  • [4] Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Nomoto, Masahiro
    Mizuno, Yoshikuni
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    JOURNAL OF NEUROLOGY, 2014, 261 (10) : 1887 - 1893
  • [5] Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
    Masahiro Nomoto
    Yoshikuni Mizuno
    Tomoyoshi Kondo
    Kazuko Hasegawa
    Miho Murata
    Masahiro Takeuchi
    Junji Ikeda
    Takayuki Tomida
    Nobutaka Hattori
    Journal of Neurology, 2014, 261 : 1887 - 1893
  • [6] Comparison of desipramine and citalopram treatments for depression in Parkinson's disease:: A double-blind, randomized, placebo-controlled study
    Devos, David
    Dujardin, Kathy
    Poirot, Isabelle
    Moreau, Caroline
    Cottencin, Olivier
    Thomas, Pierre
    Destee, Alain
    Regis, Bordet
    Defebvre, Luc
    MOVEMENT DISORDERS, 2008, 23 (06) : 850 - 857
  • [7] A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease
    Wermuth, L
    EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (03) : 235 - 242
  • [8] A double-blind placebo-controlled study of the efficacy of a single dose of subcutaneous apomorphine in advanced Parkinson's disease
    Koller, W
    NEUROLOGY, 2004, 62 (07) : A329 - A329
  • [9] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [10] Rivastigmine in dementia associated with Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Emre, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 298 - 298
12345